Skip links

Author: crjfinlayson

PharmaCielo processing equipment

PharmaCielo Provides Update on GMP Compliance Process

Colombian and Mexican GMP certifications expected during Q1'21 and Q2'21, respectively The Company confirms that its recently completed Processing and Extraction Center at its Rionegro facility, Colombia's largest scale processing centre, will be producing extracts in compliance with EU-GMP guidelines by the end of February. TORONTO and RIONEGRO, Colombia,
UN Flag

PharmaCielo Welcomes Landmark United Nations Decision

PharmaCielo Welcomes Landmark United Nations Decision to Remove Cannabis From Narcotic Drugs List TORONTO, Canada (December 3, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (“PharmaCielo Holdings”), commends
Dana Rohrabacher US Congressman (Ret.)

Cannabis Momentum in the New US Political Landscape

December 20, 2020 By Dana Rohrabacher, former U.S. Congressman and PharmaCielo Advisor Here at home-base USA and throughout the world, major changes in the status of cannabis can be expected in the year ahead. After decades of senseless debate and destructive enforcement, there is now
Henning von Koss, CEO, PharmaCielo

PharmaCielo Ltd. Announces New Leadership

David Attard and Board of Directors reach mutual agreement under which David will step down as Chief Executive Officer and PharmaCielo board member, effective December 1st, 2020. Henning von Koss, currently President and a member of PharmaCielo’s Board of Directors, formerly with Bayer and 30-year
PharmaCielo Processing & Extraction Center photo

PharmaCielo Announces Closing of $10M Private Placement

TORONTO, Ontario (November 23, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) is pleased to announce the closing of its previously announced private placement of units ("Units") of the Company for gross proceeds of $10.0 million. “The closing of this offering further strengthens the Company’s balance sheet